Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Zhi Liu

Showing results (131-140 of 191) with videos related to

Pageof 20
Sort By:
Chinese Journal of Cancer|September 11, 2013
Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinomaChang-Juan Tao, Xu Liu, Ling-Long Tang, et al.
European Radiology|March 16, 2019
Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroupsEn-Hong Zhuo, Wei-Jing Zhang, Hao-Jiang Li, et al.
Oncotarget|March 24, 2016
Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus statusHao Peng, Lei Chen, Yuan Zhang, et al.
Biomed Research International|April 18, 2015
Prognostic value of classifying parapharyngeal extension in nasopharyngeal carcinoma based on magnetic resonance imagingGuo-Yi Zhang, Ying Huang, Xue-Feng Hu, et al.
Chinese Journal of Cancer|August 29, 2013
Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapyChang-Juan Tao, Xu Liu, Ling-Long Tang, et al.
Oral Oncology|March 31, 2018
Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma: A big-data intelligence platform-based analysisHao Peng, Ling-Long Tang, Bin-Bin Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2015
Comorbidity predicts poor prognosis in nasopharyngeal carcinoma: development and validation of a predictive score modelRui Guo, Xiao-Zhong Chen, Lei Chen, et al.
The Oncologist|August 8, 2018
10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal CarcinomaLei Chen, Yuan Zhang, Shu-Zhen Lai, et al.
Oncotarget|April 13, 2016
Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinomaRui Guo, Yan-Ping Mao, Lei Chen, et al.
BMC Cancer|October 31, 2021
Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkersYing Zhu, Wang Yao, Bing-Chen Xu, et al.
Pageof 20

Showing results (131-140 of 191) with videos related to

Sort By:
Pageof 20
Chinese Journal of Cancer|September 11, 2013
Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinomaChang-Juan Tao, Xu Liu, Ling-Long Tang, et al.
European Radiology|March 16, 2019
Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroupsEn-Hong Zhuo, Wei-Jing Zhang, Hao-Jiang Li, et al.
Oncotarget|March 24, 2016
Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus statusHao Peng, Lei Chen, Yuan Zhang, et al.
Biomed Research International|April 18, 2015
Prognostic value of classifying parapharyngeal extension in nasopharyngeal carcinoma based on magnetic resonance imagingGuo-Yi Zhang, Ying Huang, Xue-Feng Hu, et al.
Chinese Journal of Cancer|August 29, 2013
Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapyChang-Juan Tao, Xu Liu, Ling-Long Tang, et al.
Oral Oncology|March 31, 2018
Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma: A big-data intelligence platform-based analysisHao Peng, Ling-Long Tang, Bin-Bin Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2015
Comorbidity predicts poor prognosis in nasopharyngeal carcinoma: development and validation of a predictive score modelRui Guo, Xiao-Zhong Chen, Lei Chen, et al.
The Oncologist|August 8, 2018
10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal CarcinomaLei Chen, Yuan Zhang, Shu-Zhen Lai, et al.
Oncotarget|April 13, 2016
Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinomaRui Guo, Yan-Ping Mao, Lei Chen, et al.
BMC Cancer|October 31, 2021
Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkersYing Zhu, Wang Yao, Bing-Chen Xu, et al.
Pageof 20